Free Trial

Givaudan SA (OTCMKTS:GVDNY) Sees Significant Growth in Short Interest

Givaudan logo with Basic Materials background
Remove Ads

Givaudan SA (OTCMKTS:GVDNY - Get Free Report) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 700 shares, an increase of 16.7% from the February 13th total of 600 shares. Based on an average trading volume of 34,700 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company's shares are short sold.

Givaudan Stock Performance

Shares of GVDNY stock traded down $2.95 during trading hours on Friday, reaching $88.45. 9,011 shares of the company traded hands, compared to its average volume of 30,226. Givaudan has a 12-month low of $83.36 and a 12-month high of $110.32. The firm has a 50-day moving average price of $88.07 and a 200 day moving average price of $92.65. The company has a quick ratio of 0.94, a current ratio of 1.43 and a debt-to-equity ratio of 0.99.

Givaudan Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, April 9th. Shareholders of record on Tuesday, March 25th will be given a dividend of $1.5503 per share. This is a boost from Givaudan's previous dividend of $0.97. The ex-dividend date is Tuesday, March 25th.

Analysts Set New Price Targets

Separately, Berenberg Bank raised Givaudan from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 14th.

Get Our Latest Analysis on GVDNY

Givaudan Company Profile

(Get Free Report)

Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.

Further Reading

Should You Invest $1,000 in Givaudan Right Now?

Before you consider Givaudan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.

While Givaudan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads